Detalhe da pesquisa
1.
Correction: SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.
Infection;
2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683470
2.
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.
Infection;
52(3): 767-786, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554253
3.
Current status in cellular-based therapies for prevention and treatment of COVID-19.
Crit Rev Clin Lab Sci;
60(5): 321-345, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825325
4.
Hydrophobic substituents increase the potency of salacinol, a potent α-glucosidase inhibitor from Ayurvedic traditional medicine 'Salacia'.
Bioorg Med Chem;
24(16): 3705-15, 2016 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325449
5.
Highly Diastereoselective Route to α-Glucosidase Inhibitors, Neosalacinol and Neoponkoranol.
J Org Chem;
81(8): 3407-15, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27015084
6.
Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor.
Bioorg Med Chem;
19(7): 2252-62, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21420866